Share Price and Basic Stock Data
Last Updated: December 16, 2025, 4:05 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Elango Industries Ltd operates in the alloys and special steel segment, a niche but vital part of the broader steel industry. The company’s revenue trajectory has been tumultuous, with sales recorded at ₹0.00 Cr for several quarters until June 2023, when it finally reported ₹1.93 Cr. This marked a significant uptick but was followed by fluctuating revenues, culminating in ₹0.65 Cr in December 2023 and a projected ₹0.04 Cr for June 2024. Such volatility raises questions regarding the sustainability of its business model. The company has historically struggled to maintain consistent revenue, with total sales of ₹0.00 Cr in FY 2023 and a marginal increase to ₹2.58 Cr in FY 2024. This inconsistency suggests that while there may be potential for growth, the execution and market conditions remain uncertain.
Profitability and Efficiency Metrics
Profitability for Elango Industries paints a stark picture. The company reported a negative net profit of ₹0.17 Cr, and its operating profit margin (OPM) stood at a concerning -23.81%. This indicates that the cost structure is heavily skewed against profitability, particularly when compared to industry norms where a positive margin is expected. Furthermore, the return on equity (ROE) and return on capital employed (ROCE) both stood at 5.67%, which, while not disastrous, is below the levels one might anticipate in a healthy business environment. The company’s cash conversion cycle is relatively short at 3.80 days, suggesting it can convert its investments in inventory and receivables back into cash quickly. However, without a solid operating profit, this efficiency does little to mitigate overall financial strain.
Balance Sheet Strength and Financial Ratios
Elango Industries has maintained a conservative approach to financing, with no reported borrowings across the years, which is a notable strength. The company’s total liabilities have fluctuated, standing at ₹4.71 Cr as of FY 2025. However, reserves have taken a hit, declining to -₹0.11 Cr, indicating potential liquidity issues. The price-to-book value ratio of 0.98x suggests that the stock is trading close to its book value, which could be appealing for value investors. Yet, with a current ratio of 3.69, the company appears to have ample short-term liquidity. This could provide a cushion against operational challenges, although the lack of reserves raises concerns about its ability to weather prolonged downturns or unexpected expenses.
Shareholding Pattern and Investor Confidence
The shareholding structure of Elango Industries reveals a significant public stake of 64.79%, with promoters holding 35.20%. This distribution indicates a relatively high level of public participation, which can be a double-edged sword. On one hand, it suggests that the company has attracted retail investor interest; on the other, the lack of institutional investment—both from domestic and foreign institutional investors—might indicate a perceived risk or lack of confidence in the company’s future prospects. The number of shareholders has slightly increased to 8,621, reflecting some level of sustained interest, but the absence of larger institutional stakes could limit the stock’s growth potential and stability in times of market volatility.
Outlook, Risks, and Final Insight
Looking ahead, Elango Industries faces a challenging landscape. While there is potential for growth, demonstrated by recent revenue increases, the company must address its profitability issues to regain investor confidence. The absence of institutional backing poses a risk, as does the declining reserve position, which could affect operational flexibility. Furthermore, with the steel industry being cyclical, Elango’s ability to navigate through economic fluctuations will be crucial. Investors should consider these factors carefully, weighing the company’s recent performance against its historical challenges. The path forward will require not only consistent revenue growth but also a clear strategy to enhance profitability and strengthen the balance sheet. In this environment, cautious optimism seems warranted, but significant risks remain that could impact future performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Elango Industries Ltd | 4.73 Cr. | 12.4 | 16.1/8.45 | 9.72 | 0.00 % | 5.67 % | 5.67 % | 10.0 | |
| Ashnisha Industries Ltd | 87.2 Cr. | 3.29 | 4.94/2.57 | 301 | 2.30 | 0.00 % | 1.23 % | 0.28 % | 1.00 |
| Usha Martin Ltd | 14,064 Cr. | 462 | 498/279 | 33.3 | 97.3 | 0.65 % | 18.8 % | 15.8 % | 1.00 |
| Shah Alloys Ltd | 139 Cr. | 70.2 | 83.8/43.3 | 5.18 | 0.00 % | 25.8 % | 1,108 % | 10.0 | |
| Mukand Ltd | 1,917 Cr. | 133 | 162/84.4 | 29.6 | 66.3 | 1.51 % | 9.91 % | 7.84 % | 10.0 |
| Industry Average | 20,457.50 Cr | 246.32 | 96.93 | 66.63 | 0.42% | 13.27% | 192.30% | 5.67 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 1.93 | 0.00 | 0.65 | 0.00 | 0.04 | 0.00 | 0.90 | 0.01 | 0.21 |
| Expenses | 0.07 | 0.03 | 0.04 | 0.04 | 1.93 | 0.04 | 0.67 | 0.08 | 0.13 | 0.03 | 0.93 | 0.06 | 0.26 |
| Operating Profit | -0.07 | -0.03 | -0.04 | -0.04 | 0.00 | -0.04 | -0.02 | -0.08 | -0.09 | -0.03 | -0.03 | -0.05 | -0.05 |
| OPM % | 0.00% | -3.08% | -225.00% | -3.33% | -500.00% | -23.81% | |||||||
| Other Income | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.05 | -0.03 | -0.04 | -0.02 | 0.00 | -0.04 | -0.03 | -0.09 | -0.09 | -0.03 | -0.03 | -0.05 | -0.05 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Net Profit | -0.05 | -0.03 | -0.04 | -0.03 | 0.00 | -0.04 | -0.02 | -0.08 | -0.10 | -0.03 | -0.03 | -0.06 | -0.05 |
| EPS in Rs | -0.13 | -0.08 | -0.10 | -0.08 | 0.00 | -0.10 | -0.05 | -0.21 | -0.26 | -0.08 | -0.08 | -0.16 | -0.13 |
Last Updated: August 19, 2025, 7:30 pm
Below is a detailed analysis of the quarterly data for Elango Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.21 Cr.. The value appears strong and on an upward trend. It has increased from 0.01 Cr. (Mar 2025) to 0.21 Cr., marking an increase of 0.20 Cr..
- For Expenses, as of Jun 2025, the value is 0.26 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.06 Cr. (Mar 2025) to 0.26 Cr., marking an increase of 0.20 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.05 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded -0.05 Cr..
- For OPM %, as of Jun 2025, the value is -23.81%. The value appears strong and on an upward trend. It has increased from -500.00% (Mar 2025) to -23.81%, marking an increase of 476.19%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.05 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded -0.05 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Net Profit, as of Jun 2025, the value is -0.05 Cr.. The value appears strong and on an upward trend. It has increased from -0.06 Cr. (Mar 2025) to -0.05 Cr., marking an increase of 0.01 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.13. The value appears strong and on an upward trend. It has increased from -0.16 (Mar 2025) to -0.13, marking an increase of 0.03.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:48 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.29 | 0.48 | 0.51 | 0.20 | 0.15 | 0.25 | 0.55 | 0.00 | 2.58 | 0.96 | 1.15 |
| Expenses | 0.24 | 0.75 | 0.30 | 0.27 | 0.59 | 0.43 | 0.11 | 0.31 | 1.08 | 0.17 | 2.71 | 1.16 | 1.29 |
| Operating Profit | -0.24 | -0.75 | -0.01 | 0.21 | -0.08 | -0.23 | 0.04 | -0.06 | -0.53 | -0.17 | -0.13 | -0.20 | -0.14 |
| OPM % | -3.45% | 43.75% | -15.69% | -115.00% | 26.67% | -24.00% | -96.36% | -5.04% | -20.83% | -12.17% | |||
| Other Income | 0.15 | 0.00 | 0.61 | 0.01 | 0.01 | 0.00 | 0.00 | 0.11 | 0.11 | 0.05 | 0.01 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 | 0.02 | 0.02 | 0.00 |
| Profit before tax | -0.11 | -0.75 | 0.60 | 0.22 | -0.07 | -0.23 | 0.04 | 0.05 | -0.45 | -0.14 | -0.14 | -0.22 | -0.14 |
| Tax % | 0.00% | 0.00% | 0.00% | 18.18% | 0.00% | 0.00% | 0.00% | 20.00% | 0.00% | 0.00% | 7.14% | 0.00% | |
| Net Profit | -0.10 | -0.75 | 0.60 | 0.18 | -0.07 | -0.23 | 0.04 | 0.04 | -0.45 | -0.15 | -0.14 | -0.22 | -0.15 |
| EPS in Rs | -0.26 | -1.97 | 1.57 | 0.47 | -0.18 | -0.60 | 0.10 | 0.10 | -1.18 | -0.39 | -0.37 | -0.58 | -0.40 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -650.00% | 180.00% | -70.00% | -138.89% | -228.57% | 117.39% | 0.00% | -1225.00% | 66.67% | 6.67% | -57.14% |
| Change in YoY Net Profit Growth (%) | 0.00% | 830.00% | -250.00% | -68.89% | -89.68% | 345.96% | -117.39% | -1225.00% | 1291.67% | -60.00% | -63.81% |
Elango Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 45% |
| 3 Years: | 20% |
| TTM: | 62% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | % |
| 3 Years: | 15% |
| TTM: | 29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 33% |
| 3 Years: | 13% |
| 1 Year: | -15% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -4% |
| 3 Years: | -4% |
| Last Year: | -6% |
Last Updated: September 5, 2025, 3:21 pm
Balance Sheet
Last Updated: December 4, 2025, 2:48 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 |
| Reserves | 1.15 | 0.31 | 0.91 | 1.09 | 1.02 | 0.79 | 0.83 | 0.91 | 0.46 | 0.31 | 0.17 | -0.05 | -0.11 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.06 | 0.06 | 0.07 | 0.07 | 0.13 | 0.04 | 0.04 | 0.10 | 0.07 | 2.40 | 0.74 | 0.94 | 1.04 |
| Total Liabilities | 5.03 | 4.19 | 4.80 | 4.98 | 4.97 | 4.65 | 4.69 | 4.83 | 4.35 | 6.53 | 4.73 | 4.71 | 4.75 |
| Fixed Assets | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.03 | 0.14 | 0.12 | 0.11 | 0.10 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 3.06 | 3.06 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 1.88 | 1.13 | 4.77 | 4.95 | 4.94 | 4.62 | 4.66 | 4.74 | 4.32 | 6.39 | 4.61 | 4.60 | 4.65 |
| Total Assets | 5.03 | 4.19 | 4.80 | 4.98 | 4.97 | 4.65 | 4.69 | 4.83 | 4.35 | 6.53 | 4.73 | 4.71 | 4.75 |
Below is a detailed analysis of the balance sheet data for Elango Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 3.82 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.82 Cr..
- For Reserves, as of Sep 2025, the value is -0.11 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -0.05 Cr. (Mar 2025) to -0.11 Cr., marking a decline of 0.06 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. However, Reserves are negative, which is a major warning sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1.04 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.94 Cr. (Mar 2025) to 1.04 Cr., marking an increase of 0.10 Cr..
- For Total Liabilities, as of Sep 2025, the value is 4.75 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.71 Cr. (Mar 2025) to 4.75 Cr., marking an increase of 0.04 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.10 Cr.. The value appears to be declining and may need further review. It has decreased from 0.11 Cr. (Mar 2025) to 0.10 Cr., marking a decrease of 0.01 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 4.65 Cr.. The value appears strong and on an upward trend. It has increased from 4.60 Cr. (Mar 2025) to 4.65 Cr., marking an increase of 0.05 Cr..
- For Total Assets, as of Sep 2025, the value is 4.75 Cr.. The value appears strong and on an upward trend. It has increased from 4.71 Cr. (Mar 2025) to 4.75 Cr., marking an increase of 0.04 Cr..
However, the Borrowings (0.00 Cr.) are higher than the Reserves (-0.11 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.24 | -0.75 | -0.01 | 0.21 | -0.08 | -0.23 | 0.04 | -0.06 | -0.53 | -0.17 | -0.13 | -0.20 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 37.76 | 0.00 | 393.63 | 1,387.00 | 1,849.33 | 116.80 | 0.00 | 0.00 | 3.80 | |||
| Inventory Days | 0.00 | 0.00 | ||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 37.76 | 0.00 | 393.63 | 1,387.00 | 1,849.33 | 116.80 | 0.00 | 0.00 | 3.80 | |||
| Working Capital Days | 4,505.86 | -53.23 | 307.75 | 6,205.00 | 3,260.67 | 1,854.20 | 132.73 | 367.83 | 908.70 | |||
| ROCE % | -2.19% | -16.48% | 13.54% | 4.56% | -1.44% | -4.87% | 0.86% | 1.07% | -9.99% | -3.33% | -3.45% | -5.67% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.57 | -0.38 | -0.40 | -1.18 | 0.11 |
| Diluted EPS (Rs.) | -0.57 | -0.38 | -0.40 | -1.18 | 0.11 |
| Cash EPS (Rs.) | -0.52 | -0.32 | -0.33 | -1.09 | 0.11 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 9.87 | 10.44 | 10.82 | 11.21 | 12.39 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 9.87 | 10.44 | 10.82 | 11.21 | 12.39 |
| Revenue From Operations / Share (Rs.) | 2.51 | 6.75 | 0.00 | 1.44 | 0.65 |
| PBDIT / Share (Rs.) | -0.51 | -0.30 | -0.32 | -1.10 | 0.14 |
| PBIT / Share (Rs.) | -0.55 | -0.36 | -0.38 | -1.19 | 0.14 |
| PBT / Share (Rs.) | -0.55 | -0.36 | -0.38 | -1.19 | 0.14 |
| Net Profit / Share (Rs.) | -0.56 | -0.37 | -0.39 | -1.18 | 0.11 |
| PBDIT Margin (%) | -20.58 | -4.52 | -6510.52 | -76.52 | 21.96 |
| PBIT Margin (%) | -22.25 | -5.33 | -7705.26 | -82.68 | 21.88 |
| PBT Margin (%) | -22.25 | -5.33 | -7705.26 | -82.68 | 21.88 |
| Net Profit Margin (%) | -22.61 | -5.61 | -7931.57 | -81.87 | 17.05 |
| Return on Networth / Equity (%) | -5.74 | -3.62 | -3.64 | -10.49 | 0.90 |
| Return on Capital Employeed (%) | -5.58 | -3.40 | -3.53 | -10.59 | 1.15 |
| Return On Assets (%) | -4.60 | -3.05 | -2.30 | -10.32 | 0.88 |
| Asset Turnover Ratio (%) | 0.20 | 0.45 | 0.00 | 0.11 | 0.05 |
| Current Ratio (X) | 3.69 | 4.73 | 2.09 | 44.05 | 15.06 |
| Quick Ratio (X) | 3.69 | 4.73 | 2.09 | 44.05 | 15.06 |
| Enterprise Value (Cr.) | 3.73 | 4.06 | 1.53 | 1.85 | 0.81 |
| EV / Net Operating Revenue (X) | 3.89 | 1.57 | 804.07 | 3.37 | 3.23 |
| EV / EBITDA (X) | -18.89 | -34.74 | -12.35 | -4.41 | 14.72 |
| MarketCap / Net Operating Revenue (X) | 3.89 | 1.57 | 1661.39 | 8.50 | 3.44 |
| Price / BV (X) | 0.98 | 1.02 | 0.76 | 1.09 | 0.18 |
| Price / Net Operating Revenue (X) | 3.89 | 1.57 | 2065.00 | 8.50 | 3.44 |
| EarningsYield | -0.05 | -0.03 | -0.04 | -0.09 | 0.04 |
After reviewing the key financial ratios for Elango Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.57. This value is below the healthy minimum of 5. It has decreased from -0.38 (Mar 24) to -0.57, marking a decrease of 0.19.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.57. This value is below the healthy minimum of 5. It has decreased from -0.38 (Mar 24) to -0.57, marking a decrease of 0.19.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.52. This value is below the healthy minimum of 3. It has decreased from -0.32 (Mar 24) to -0.52, marking a decrease of 0.20.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 9.87. It has decreased from 10.44 (Mar 24) to 9.87, marking a decrease of 0.57.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 9.87. It has decreased from 10.44 (Mar 24) to 9.87, marking a decrease of 0.57.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2.51. It has decreased from 6.75 (Mar 24) to 2.51, marking a decrease of 4.24.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -0.51. This value is below the healthy minimum of 2. It has decreased from -0.30 (Mar 24) to -0.51, marking a decrease of 0.21.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.55. This value is below the healthy minimum of 0. It has decreased from -0.36 (Mar 24) to -0.55, marking a decrease of 0.19.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.55. This value is below the healthy minimum of 0. It has decreased from -0.36 (Mar 24) to -0.55, marking a decrease of 0.19.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.56. This value is below the healthy minimum of 2. It has decreased from -0.37 (Mar 24) to -0.56, marking a decrease of 0.19.
- For PBDIT Margin (%), as of Mar 25, the value is -20.58. This value is below the healthy minimum of 10. It has decreased from -4.52 (Mar 24) to -20.58, marking a decrease of 16.06.
- For PBIT Margin (%), as of Mar 25, the value is -22.25. This value is below the healthy minimum of 10. It has decreased from -5.33 (Mar 24) to -22.25, marking a decrease of 16.92.
- For PBT Margin (%), as of Mar 25, the value is -22.25. This value is below the healthy minimum of 10. It has decreased from -5.33 (Mar 24) to -22.25, marking a decrease of 16.92.
- For Net Profit Margin (%), as of Mar 25, the value is -22.61. This value is below the healthy minimum of 5. It has decreased from -5.61 (Mar 24) to -22.61, marking a decrease of 17.00.
- For Return on Networth / Equity (%), as of Mar 25, the value is -5.74. This value is below the healthy minimum of 15. It has decreased from -3.62 (Mar 24) to -5.74, marking a decrease of 2.12.
- For Return on Capital Employeed (%), as of Mar 25, the value is -5.58. This value is below the healthy minimum of 10. It has decreased from -3.40 (Mar 24) to -5.58, marking a decrease of 2.18.
- For Return On Assets (%), as of Mar 25, the value is -4.60. This value is below the healthy minimum of 5. It has decreased from -3.05 (Mar 24) to -4.60, marking a decrease of 1.55.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.20. It has decreased from 0.45 (Mar 24) to 0.20, marking a decrease of 0.25.
- For Current Ratio (X), as of Mar 25, the value is 3.69. This value exceeds the healthy maximum of 3. It has decreased from 4.73 (Mar 24) to 3.69, marking a decrease of 1.04.
- For Quick Ratio (X), as of Mar 25, the value is 3.69. This value exceeds the healthy maximum of 2. It has decreased from 4.73 (Mar 24) to 3.69, marking a decrease of 1.04.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3.73. It has decreased from 4.06 (Mar 24) to 3.73, marking a decrease of 0.33.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.89. This value exceeds the healthy maximum of 3. It has increased from 1.57 (Mar 24) to 3.89, marking an increase of 2.32.
- For EV / EBITDA (X), as of Mar 25, the value is -18.89. This value is below the healthy minimum of 5. It has increased from -34.74 (Mar 24) to -18.89, marking an increase of 15.85.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.89. This value exceeds the healthy maximum of 3. It has increased from 1.57 (Mar 24) to 3.89, marking an increase of 2.32.
- For Price / BV (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 1.02 (Mar 24) to 0.98, marking a decrease of 0.04.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.89. This value exceeds the healthy maximum of 3. It has increased from 1.57 (Mar 24) to 3.89, marking an increase of 2.32.
- For EarningsYield, as of Mar 25, the value is -0.05. This value is below the healthy minimum of 5. It has decreased from -0.03 (Mar 24) to -0.05, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Elango Industries Ltd:
- Net Profit Margin: -22.61%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -5.58% (Industry Average ROCE: 13.27%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -5.74% (Industry Average ROE: 192.3%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.69
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 96.93)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -22.61%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Steel - Alloys/Special | No.5, Ranganathan Garden, 15th Main Road Extension, Chennai (Madras) Tamil Nadu 600040 | admin@kaveripower.com www.elangoindustries.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. S Elangovan | Managing Director |
| Mr. S A Premkumar | Director |
| Dr. M Ramasamy | Independent Director |
| Ms. Preethi Natarajan | Independent Director |
| Mrs. Asitha K | Independent Director |
FAQ
What is the intrinsic value of Elango Industries Ltd?
Elango Industries Ltd's intrinsic value (as of 15 December 2025) is 6.75 which is 45.56% lower the current market price of 12.40, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 4.73 Cr. market cap, FY2025-2026 high/low of 16.1/8.45, reserves of ₹-0.11 Cr, and liabilities of 4.75 Cr.
What is the Market Cap of Elango Industries Ltd?
The Market Cap of Elango Industries Ltd is 4.73 Cr..
What is the current Stock Price of Elango Industries Ltd as on 15 December 2025?
The current stock price of Elango Industries Ltd as on 15 December 2025 is 12.4.
What is the High / Low of Elango Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Elango Industries Ltd stocks is 16.1/8.45.
What is the Stock P/E of Elango Industries Ltd?
The Stock P/E of Elango Industries Ltd is .
What is the Book Value of Elango Industries Ltd?
The Book Value of Elango Industries Ltd is 9.72.
What is the Dividend Yield of Elango Industries Ltd?
The Dividend Yield of Elango Industries Ltd is 0.00 %.
What is the ROCE of Elango Industries Ltd?
The ROCE of Elango Industries Ltd is 5.67 %.
What is the ROE of Elango Industries Ltd?
The ROE of Elango Industries Ltd is 5.67 %.
What is the Face Value of Elango Industries Ltd?
The Face Value of Elango Industries Ltd is 10.0.